Ascentis Independent Advisors Buys 2,294 Shares of Cencora, Inc. $COR

Ascentis Independent Advisors raised its stake in shares of Cencora, Inc. (NYSE:COR) by 109.0% during the 1st quarter, Holdings Channel.com reports. The fund owned 4,399 shares of the company’s stock after acquiring an additional 2,294 shares during the period. Ascentis Independent Advisors’ holdings in Cencora were worth $1,382,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of COR. Kemnay Advisory Services Inc. purchased a new stake in shares of Cencora in the fourth quarter valued at about $25,000. Oakworth Capital Inc. bought a new stake in Cencora in the 4th quarter worth about $26,000. Elyxium Wealth LLC purchased a new stake in Cencora in the 4th quarter valued at about $27,000. Archer Investment Corp lifted its position in shares of Cencora by 134.3% during the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after buying an additional 47 shares in the last quarter. Finally, Motiv8 Investments LLC bought a new position in shares of Cencora during the 4th quarter worth approximately $29,000. 97.52% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on COR shares. UBS Group upped their target price on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Wells Fargo & Company cut their price objective on Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a research report on Monday, May 11th. Evercore set a $360.00 price objective on Cencora in a research note on Wednesday, April 8th. Morgan Stanley set a $342.00 target price on Cencora in a research report on Friday, May 8th. Finally, William Blair started coverage on Cencora in a research note on Tuesday, April 28th. They set a “market perform” rating on the stock. Eleven equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $367.75.

Insider Buying and Selling

In other Cencora news, Director Lauren M. Tyler acquired 550 shares of the company’s stock in a transaction on Monday, June 22nd. The shares were acquired at an average cost of $270.23 per share, with a total value of $148,626.50. Following the completion of the acquisition, the director directly owned 4,359 shares in the company, valued at $1,177,932.57. This trade represents a 14.44% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.38% of the stock is currently owned by company insiders.

Cencora Price Performance

Cencora stock opened at $298.80 on Tuesday. The business’s 50 day simple moving average is $277.66 and its 200 day simple moving average is $319.86. Cencora, Inc. has a 12 month low of $244.82 and a 12 month high of $377.54. The company has a market cap of $58.13 billion, a price-to-earnings ratio of 22.91, a PEG ratio of 1.65 and a beta of 0.58. The company has a current ratio of 0.95, a quick ratio of 0.59 and a debt-to-equity ratio of 3.40.

Cencora (NYSE:COR) last issued its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The firm had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. During the same quarter in the previous year, the firm earned $4.42 earnings per share. The business’s quarterly revenue was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Sell-side analysts forecast that Cencora, Inc. will post 17.79 EPS for the current year.

Cencora Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date was Friday, May 15th. Cencora’s payout ratio is currently 18.40%.

Cencora announced that its Board of Directors has approved a share buyback plan on Thursday, May 21st that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the company to purchase up to 3.9% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its stock is undervalued.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.